The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pricing and Final Results

7 Apr 2016 12:44

RNS Number : 5278U
Royal Bank of Scotland Group PLC
07 April 2016
 

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (THE "UNITED STATES") OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT.

7 April 2016

THE ROYAL BANK OF SCOTLAND GROUP PLC AND THE ROYAL BANK OF SCOTLAND PLC ANNOUNCE PRICING AND FINAL RESULTS OF CASH TENDER OFFERS FOR CERTAIN EURO AND POUNDS STERLING NOTES

On 30 March 2016, The Royal Bank of Scotland Group plc ("RBSG plc") and The Royal Bank of Scotland plc ("RBS plc") (each an "Offeror", and together the "Offerors") separately invited Holders of the notes issued by them and listed below (together the "Notes", and each a "Series") to tender their Notes for purchase by the relevant Offeror for cash (each an "Offer", and together, the "Offers") on the terms of, and subject to the conditions contained in, a tender offer memorandum dated 30 March 2016 (the "Tender Offer Memorandum").

Capitalised terms used but not otherwise defined in this announcement have the same meaning as assigned to them in the Tender Offer Memorandum.

Each Offeror hereby announces that it will accept for purchase all Notes validly tendered under the relevant Offers and that:

(i) the aggregate principal amount of each Series of Notes validly accepted for purchase;

(ii) the relevant Purchase Price in respect of each Series of Notes so accepted; and

(iii) the relevant Fixed Spread Note Purchase Yield and Benchmark Rate for each Series of the Fixed Spread Notes so accepted,

are as follows:

Title of Series

ISIN / Common Code

Issuer and Offeror

Current Principal Amount Outstanding (Principal Amount Outstanding post-settlement of the Offers)

Aggregate Principal Amount accepted for purchase

Relevant Benchmark Rate

Fixed Spread Note Purchase Yield

Purchase Price*

Accrued Interest**

Fixed Yield Notes

€1,250,000,000 1.50 per cent. Notes due 2016

XS0997797054 / 099779705

RBSG plc

€1,250,000,000

(€406,113,000)

€843,887,000

N/A

N/A

100.947%

€5.53

€2,000,000,000 4.875 per cent. Notes due 2017

XS0480133338 / 048013333

RBS plc

€890,250,000

(€799,800,000)

€90,450,000

N/A

N/A

103.783%

€10.92

Fixed Spread Notes

£519,943,000 6.00 per cent. Notes due 2017

XS0497707744 / 049770774

RBS plc

£148,445,000

(£132,173,000)

£16,272,000

0.365%

1.018%

105.412%

£54.10

€1,000,000,000 1.625 per cent. Notes due 2019

XS1080952960 / 108095296

RBSG plc

€1,000,000,000

(€582,979,000)

€417,021,000

-0.118%

1.032%

101.859%

€12.92

£924,613,000 7.50 per cent. Notes due 2024

XS0423325181 / 042332518

RBS plc

£306,186,000

(£96,252,000)

£209,934,000

1.271%

2.471%

136.502%

£33.81

£739,033,000 6.875 per cent. Notes due 2025

XS0497709286 / 049770928

RBS plc

£219,620,000

(£77,351,000)

£142,269,000

1.254%

2.722%

133.064%

£61.99

£125,000,000 6.375 per cent. Notes due 2028

XS0107382532 / 010738253

RBS plc

£45,216,000

(£34,425,000)

£10,791,000

1.560%

3.236%

132.158%

£21.96

 

* expressed as a percentage of the principal amount of the relevant Notes accepted for purchase pursuant to the relevant Offer

** Accrued Interest per €1,000 or £1,000, as applicable, in principal amount of the relevant Notes. Accrued Interest represents interest accrued and unpaid on the relevant Notes from (and including) the immediately preceding interest payment date for such Notes to (but excluding) the Settlement Date.

General

Payment of the relevant Purchase Price and applicable Accrued Interest in respect of Notes accepted pursuant to the Offers is expected to take place on 11 April 2016. Following settlement of the Offers, each Offeror intends to cancel any Notes purchased pursuant to the Offers.

Notes that are not tendered or accepted for purchase pursuant to the relevant Offer will remain outstanding.

FURTHER INFORMATION

Lucid Issuer Services Limited has been appointed by the Offeror as Tender Agent (the "Tender Agent") for the purposes of the Offers.

The Royal Bank of Scotland plc has been appointed as Global Arranger and Lead Dealer Manager, Goldman Sachs International has been appointed as Joint Dealer Manager and ABN AMRO Bank N.V., Banca IMI S.p.A., Société Générale and UniCredit Bank AG have been appointed as the Co-Dealer Managers (the "Co-Dealer Managers") (together, with the Global Arranger and Lead Dealer Manager and the Joint Dealer Manager, the "Dealer Managers") in connection with the Offers.

Requests for information and for any documents or materials relating to the Offers should be directed to:

GLOBAL ARRANGER AND LEAD DEALER MANAGER

The Royal Bank of Scotland plc

135 Bishopsgate

London EC2M 3URUnited Kingdom

Telephone: +44 20 7085 3781

Attention: Liability Management Group

Email: liabilitymanagement@rbs.com

JOINT DEALER MANAGER

Goldman Sachs InternationalPeterborough Court133 Fleet StreetLondon EC4A 2BBUnited Kingdom

Telephone: +44 20 7774 9862Attention: Liability Management GroupEmail: liabilitymanagement.eu@gs.com

 

TENDER AGENT

Lucid Issuer Services Limited

Tankerton Works

12 Argyle Walk

London WC1H 8HA

United Kingdom

Telephone: +44 20 7704 0880

Attention: David Shilson

Email: rbs@lucid-is.com

 

 

 

DISCLAIMER

Subject to applicable law, the Offerors or any of their respective affiliates may at any time and from time to time following completion of the Offers purchase remaining outstanding Notes by tender, in the open market, by private agreement or otherwise on such terms and at such prices as the relevant Offeror, or if applicable, its affiliates may determine. Such terms, consideration and prices may be more or less favourable than those offered pursuant to the Offers.

This announcement must be read in conjunction with the Tender Offer Memorandum. This announcement and the Tender Offer Memorandum contain important information which must be read carefully. If any holder of Notes is in any doubt as to the action it should take, it is recommended to seek its own legal, tax, accounting and financial advice, including as to any tax consequences, from its broker, bank manager, solicitor, accountant or other independent financial or legal adviser. None of the Offerors, the Dealer Managers, the Tender Agent and any person who controls, or is a director, officer, employee or agent of such persons, or any affiliate of such persons, makes any recommendation in connection with the Offers.

OFFER AND DISTRIBUTION RESTRICTIONS

This announcement and the Tender Offer Memorandum do not constitute an offer or an invitation to participate in the Offers in the United States or in any other jurisdiction in which, or to any person to or from whom, it is unlawful to make such offer or invitation or for there to be such participation under applicable securities laws. The distribution of this announcement and/or the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum comes are required by each of the Offerors, the Dealer Managers and the Tender Agent to inform themselves about, and to observe, any such restrictions.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSUFFWFMSEDL
Date   Source Headline
17th Apr 201911:20 amRNSSegmental Reporting Restatement Document
1st Apr 20194:30 pmRNSDirector/PDMR Shareholding
29th Mar 20195:04 pmRNSTotal Voting Rights
27th Mar 20192:05 pmRNSPublication of Final Terms
20th Mar 201910:17 amRNSRBSG pricing of US$2 billion of Senior Notes
19th Mar 20198:30 amRNSMorgan Stanley European Financials Conference
13th Mar 20196:26 pmRNSNotice of Redemption
11th Mar 20193:00 pmRNSDirector/PDMR Shareholding
7th Mar 20194:56 pmRNSForm 8.3 - Findel plc
6th Mar 20192:45 pmRNSForm 8.3 - MedicX Fund Limited
1st Mar 20191:10 pmRNSForm 8.3 - MedicX Fund Limited
1st Mar 201912:01 pmRNSDirector/PDMR Shareholding
1st Mar 20197:00 amRNSFiling of Annual Report on Form 20-F with US SEC
28th Feb 20192:25 pmRNSDividend Declaration
28th Feb 201912:40 pmRNSTotal Voting Rights
26th Feb 20195:50 pmRNSPublication of Supplementary Prospectus
22nd Feb 201912:51 pmRNSUpdate on NatWest Markets transfer scheme
22nd Feb 201912:00 pmRNSDirector/PDMR Shareholding
15th Feb 20193:00 pmRNSPublication of Supplementary Prospectus
15th Feb 20197:02 amRNSDirectorate Change
15th Feb 20197:01 amRNSAnnual Financial Report
15th Feb 20197:00 amRNSFinal Results
6th Feb 20194:16 pmRNSResult of Meeting
6th Feb 20192:55 pmRNSGM Statement
31st Jan 201911:42 amRNSTotal Voting Rights
29th Jan 20192:55 pmRNSDirector/PDMR Shareholding
25th Jan 20191:27 pmRNSForm 8.3 Disclosure
17th Jan 20194:10 pmRNSNotice of GM
9th Jan 20195:02 pmRNSHolding(s) in Company
31st Dec 20181:13 pmRNSTotal Voting Rights
28th Dec 20184:28 pmRNSDirector/PDMR Shareholding
27th Dec 20184:55 pmRNSDividend Declaration
18th Dec 20183:55 pmRNSDirectorate Change
14th Dec 20186:15 pmRNSRBS welcome credit ratings action by Fitch Ratings
14th Dec 20183:33 pmRNSPublication of a Prospectus
6th Dec 20184:40 pmRNSSecond Price Monitoring Extn
6th Dec 20184:35 pmRNSPrice Monitoring Extension
6th Dec 20182:16 pmRNSNatWest Markets transfer scheme
30th Nov 20182:30 pmRNSTotal Voting Rights
30th Nov 20181:12 pmRNSDirector/PDMR Shareholding
29th Nov 20184:28 pmRNSDividend Declaration
29th Nov 20184:07 pmRNSNotice of Redemption
29th Nov 201811:34 amRNSNotice of Rdemption
29th Nov 201811:33 amRNSNotice of Redemption
29th Nov 201811:31 amRNSNotice of Redemption
29th Nov 201811:31 amRNSNotice of Redemption
29th Nov 20188:00 amRNSRBS Investor Seminar: Commercial Banking
28th Nov 20185:09 pmRNS2018 Bank of England stress test results
16th Nov 201812:00 pmRNSDirector/PDMR Shareholding
9th Nov 20184:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.